Catering to the life science and healthcare sectors, software solutions provider Sensyne Health has introduced an innovative, AI-enabled global data analytics platform known as SENSIGHT. This platform embodies a deep well of patient data points that’s been aggregated from Sensyne’s numerous health organization partnerships. The company’s connections with health systems in the U.S. and NHS Hospital Trusts in the U.K. account for a patient database of over 22.5 million, with varying disease areas being well-represented due to sheer volume. Sensyne projects its data set will swell to 100 million patients by 2024.
SENSIGHT is an attractive prospect for life science and healthcare researchers seeking to reference industrial-scale health insights in an easily-accessible and curated environment. The platform gives users instantaneous AI-powered research capabilities by quickly investigating Sensyne’s broad datasets and delivering intelligent analytics and insights—a process that delves much deeper than simple data point retrieval. The system is safeguarded by an uncompromising information governance and security framework that renders all patient data de-identified.
Entry to the platform is currently based on a per-person subscription model that sets its yearly fee at $35,000 for commercial customers. Those interested must be cleared during a screening process and have an existing affiliation with an accredited company or organization.